Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TetraLogic Pharmaceuticals Corp TLOG

Healthcare Biotechnology
TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two... see more

Recent & Breaking News (GREY:TLOG)

TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB

GlobeNewswire December 29, 2016

TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock

GlobeNewswire November 2, 2016

Biotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma

PR Newswire June 16, 2016

Penny Stocks To Watch: Four Top Small Cap Stocks on Monday April 25

Accesswire April 25, 2016

Top Penny Stocks: Four Small Cap Stocks You Should Be Watching On April 15th

Accesswire April 15, 2016

Insider Alert: Here's Why These Small Caps Could Be Ready To Bounce...

Accesswire January 13, 2016

TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs

GlobeNewswire January 6, 2016

LifeSci Capital Initiates Coverage of TetraLogic Pharmaceuticals Corporation

Accesswire December 31, 2015

TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hematology Annual Meeting

GlobeNewswire November 9, 2015

TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update

GlobeNewswire November 4, 2015

TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata

GlobeNewswire November 2, 2015

Pharmaceutical Sector Due Diligence Report - Searching for Opportunities Among the Bruised Small Cap Market

Accesswire October 7, 2015

TetraLogic Reports Second Quarter Financial Results and Provides Clinical Programs Update

GlobeNewswire August 5, 2015

TetraLogic to Present at the Jefferies 2015 Hepatitis B Summit

GlobeNewswire July 29, 2015

TetraLogic Provides Update on Hepatitis B Clinical Program

GlobeNewswire July 20, 2015

TetraLogic Provides Update on Hepatitis B Clinical Program

GlobeNewswire July 20, 2015

TetraLogic Announces Update on MDS Clinical Program

GlobeNewswire June 30, 2015

TetraLogic Announces Termination of Public Offering

GlobeNewswire May 6, 2015

TetraLogic Announces Temporary Halt of Chronic Hepatitis B Trial

GlobeNewswire May 6, 2015

TetraLogic Announces Pricing of $25 Million Public Offering

GlobeNewswire May 1, 2015